Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Visionary Venture Fund is a life sciences venture capital fund located in Newport Beach, California. The firm focuses on investing in the ophthalmology and medical aesthetics sectors, targeting companies from Series A to commercialization. They currently manage a portfolio of 12 companies, emphasizing partnerships with Key Opinion Leaders to enhance investment decisions.
This fund invests between $5 million and $15 million in startups addressing unmet needs in ophthalmology and medical aesthetics. Their investment strategy includes collaboration with industry experts to mitigate risks and improve decision-making. Visionary Venture Fund primarily targets companies at the Series A stage and beyond.
Notable portfolio companies include Aurion Biotech, a clinical-stage biotech company developing regenerative therapies for corneal edema; Centricity Vision, creator of the Zepto precision pulse device for capsulotomy; and RxSight, which innovates intraocular lens technology for cataract surgery. Other companies include CorneaGen, IanTech, and Tarsus Pharmaceuticals.
Submit your pitch through their form at visionaryvc.com.
Yes, Visionary Venture Fund often leads investment rounds, particularly in Series A and A+ stages.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress and alignment with their focus areas.
The specific fund size is not disclosed, but they typically invest between $5 million and $15 million per company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.